TRANXENE

This brand name is authorized in France, Lithuania, Netherlands, Poland, Tunisia, United States

Active ingredients

The drug TRANXENE contains one active pharmaceutical ingredient (API):

1 Clorazepate UNII 63FN7G03XY - CLORAZEPATE DIPOTASSIUM

Clorazepate is a benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. Clorazepate exerts its effect by de-activating the nervous system through potentiation of the inhibitory effect of gamma-aminobutyric acid (GABA) on the GABA-A receptors by binding to a site that is distinct from the GABA binding site. Read about Clorazepate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRANXENE Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05BA05	Potassium clorazepate	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 62416105, 67956742, 68494908, 68644101
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1001901, 1001902, 1093496, 1093497, 1093498, 1093499, 1093500, 1093501
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 22020, 41807, 7684, 7692
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100067544, 100067550, 100067567, 100278212, 100291715, 100324981, 100335476, 100335750, 100335766, 100350620, 100354195, 100362600, 100363260, 100363343, 100365626, 100365840, 100369794, 100370774, 100380130, 100408732, 100409513, 100412320, 100414431, 100418015, 100460489
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6250212, 6250213
Country: US	FDA, National Drug Code	Identifier(s): 55292-304